BMI and All-Cause Mortality in Normoglycemia, Impaired Fasting Glucose, Newly Diagnosed Diabetes, and Prevalent Diabetes: A Cohort Study

被引:56
作者
Lee, Eun Young [1 ]
Lee, Yong-ho [2 ]
Yi, Sang-Wook [3 ]
Shin, Soon-Ae [4 ]
Yi, Jee-Jeon [5 ]
机构
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[3] Catholic Kwandong Univ, Coll Med, Dept Prevent Med & Publ Hlth, Kangnung, South Korea
[4] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, South Korea
[5] Catholic Kwandong Univ, Inst Occupat & Environm Hlth, Kangnung, South Korea
关键词
PEPTIDE CREATININE RATIO; URINARY C-PEPTIDE; YOUNG MODY; CLINICAL-DIAGNOSIS; ORAL SULFONYLUREAS; MUTATIONS; TYPE-2; ADOLESCENTS; POPULATION; CHILDREN;
D O I
10.2337/dc16-1458
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
OBJECTIVE This study examined associations between BMI and mortality in individuals with normoglycemia, impaired fasting glucose (IFG), newly diagnosed diabetes, and prevalent diabetes and identified BMI ranges associated with the lowest mortality in each group. RESEARCH DESIGN AND METHODS A total of 12,815,006 adults were prospectively monitored until 2013. Diabetes status was defined as follows: normoglycemia (fasting glucose <100 mg/dL), IFG (100-125 mg/dL), newly diagnosed diabetes (>= 126 mg/dL), and prevalent diabetes (self-reported). BMI (kg/m(2)) was measured. Cox proportional hazards model hazard ratios were calculated after adjusting for confounders. RESULTS During a mean follow-up period of 10.5 years, 454,546 men and 239,877 women died. U-shaped associations were observed regardless of diabetes status, sex, age, and smoking history. Optimal BMI (kg/m2) for the lowest mortality by group was 23.5-27.9 (normoglycemia), 25-27.9 (IFG), 25-29.4 (newly diagnosed diabetes), and 26.5-29.4 (prevalent diabetes). Higher optimal BMI by worsening diabetes status was more prominent in younger ages, especially in women. The relationship between worsening diabetes status and higher mortality was stronger with lower BMI, especially at younger ages. Given the same BMI, people with prevalent diabetes had higher mortality compared with those with newly diagnosed diabetes, and this was more striking in women than men. CONCLUSIONS U-curve relationships existed regardless of diabetes status. Optimal BMI for lowest mortality became gradually higher with worsening diabetes for each sex and each age-group.
引用
收藏
页码:1026 / 1033
页数:8
相关论文
共 32 条
[1]
Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes [J].
Besser, Rachel E. J. ;
Shields, Beverley M. ;
Hammersley, Suzanne E. ;
Colclough, Kevin ;
McDonald, Timothy J. ;
Gray, Zoe ;
Heywood, James J. N. ;
Barrett, Timothy G. ;
Hattersley, Andrew T. .
PEDIATRIC DIABETES, 2013, 14 (03) :181-188
[2]
Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes [J].
Besser, Rachel E. J. ;
Shepherd, Maggie H. ;
McDonald, Timothy J. ;
Shields, Beverley M. ;
Knight, Bridget A. ;
Ellard, Sian ;
Hattersley, Andrew T. .
DIABETES CARE, 2011, 34 (02) :286-291
[3]
Clinical Applications of Diabetes Antibody Testing [J].
Bingley, Polly J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) :25-33
[4]
Characteristics of maturity onset diabetes of the young in a large diabetes center [J].
Chambers, Christina ;
Fouts, Alexandra ;
Dong, Fran ;
Colclough, Kevin ;
Wang, Zhenyuan ;
Batish, Sat Dev ;
Jaremko, Malgorzata ;
Ellard, Sian ;
Hattersley, Andrew T. ;
Klingensmith, Georgeanna ;
Steck, Andrea K. .
PEDIATRIC DIABETES, 2016, 17 (05) :360-367
[5]
COLE P, 1980, JNCI-J NATL CANCER I, V64, P1263
[6]
'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle [J].
Dixon, J. B. ;
Egger, G. J. ;
Finkelstein, E. A. ;
Kral, J. G. ;
Lambert, G. W. .
INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (01) :82-84
[7]
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing [J].
Ellard, S. ;
Allen, H. Lango ;
De Franco, E. ;
Flanagan, S. E. ;
Hysenaj, G. ;
Colclough, K. ;
Houghton, J. A. L. ;
Shepherd, M. ;
Hattersley, A. T. ;
Weedon, M. N. ;
Caswell, R. .
DIABETOLOGIA, 2013, 56 (09) :1958-1963
[8]
Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes [J].
Gandica, Rachelle G. ;
Chung, Wendy K. ;
Deng, Liyong ;
Goland, Robin ;
Gallagher, Mary Pat .
PEDIATRIC DIABETES, 2015, 16 (03) :227-233
[9]
Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry [J].
Irgens, H. U. ;
Molnes, J. ;
Johansson, B. B. ;
Ringdal, M. ;
Skrivarhaug, T. ;
Undlien, D. E. ;
Sovik, O. ;
Joner, G. ;
Molven, A. ;
Njolstad, P. R. .
DIABETOLOGIA, 2013, 56 (07) :1512-1519
[10]
Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry [J].
Johansson, Bente B. ;
Irgens, Henrik U. ;
Molnes, Janne ;
Sztromwasser, Pawel ;
Aukrust, Ingvild ;
Juliusson, Petur B. ;
Sovik, Oddmund ;
Levy, Shawn ;
Skrivarhaug, Torild ;
Joner, Geir ;
Molven, Anders ;
Johansson, Stefan ;
Njolstad, Pal R. .
DIABETOLOGIA, 2017, 60 (04) :625-635